203 related articles for article (PubMed ID: 10871316)
1. An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists.
Pulito VL; Li X; Varga SS; Mulcahy LS; Clark KS; Halbert SA; Reitz AB; Murray WV; Jolliffe LK
J Pharmacol Exp Ther; 2000 Jul; 294(1):224-9. PubMed ID: 10871316
[TBL] [Abstract][Full Text] [Related]
2. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
Nanda K; Naruganahalli KS; Gupta S; Malhotra S; Tiwari A; Hegde LG; Jain S; Sinha N; Gupta JB; Chugh A; Anand N; Ray A
Eur J Pharmacol; 2009 Apr; 607(1-3):213-9. PubMed ID: 19239913
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I.
Leonardi A; Hieble JP; Guarneri L; Naselsky DP; Poggesi E; Sironi G; Sulpizio AC; Testa R
J Pharmacol Exp Ther; 1997 Jun; 281(3):1272-83. PubMed ID: 9190863
[TBL] [Abstract][Full Text] [Related]
4. Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity.
Hancock AA; Brune ME; Witte DG; Marsh KC; Katwala S; Milicic I; Ireland LM; Crowell D; Meyer MD; Kerwin JF
J Pharmacol Exp Ther; 1998 May; 285(2):628-42. PubMed ID: 9580607
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.
Nagarathnam D; Wetzel JM; Miao SW; Marzabadi MR; Chiu G; Wong WC; Hong X; Fang J; Forray C; Branchek TA; Heydorn WE; Chang RS; Broten T; Schorn TW; Gluchowski C
J Med Chem; 1998 Dec; 41(26):5320-33. PubMed ID: 9857099
[TBL] [Abstract][Full Text] [Related]
7. Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists.
Martin DJ; Lluel P; Guillot E; Coste A; Jammes D; Angel I
J Pharmacol Exp Ther; 1997 Jul; 282(1):228-35. PubMed ID: 9223558
[TBL] [Abstract][Full Text] [Related]
8. A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype.
Knepper SM; Buckner SA; Brune ME; DeBernardis JF; Meyer MD; Hancock AA
J Pharmacol Exp Ther; 1995 Jul; 274(1):97-103. PubMed ID: 7616455
[TBL] [Abstract][Full Text] [Related]
9. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.
Zhao MM; Hwa J; Perez DM
Mol Pharmacol; 1996 Nov; 50(5):1118-26. PubMed ID: 8913343
[TBL] [Abstract][Full Text] [Related]
10. Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia.
Kojima Y; Sasaki S; Oda N; Koshimizu TA; Hayashi Y; Kiniwa M; Tsujimoto G; Kohri K
Prostate; 2009 Oct; 69(14):1521-8. PubMed ID: 19544328
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part II.
Testa R; Guarneri L; Angelico P; Poggesi E; Taddei C; Sironi G; Colombo D; Sulpizio AC; Naselsky DP; Hieble JP; Leonardi A
J Pharmacol Exp Ther; 1997 Jun; 281(3):1284-93. PubMed ID: 9190864
[TBL] [Abstract][Full Text] [Related]
12. Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia.
Tatemichi S; Tomiyama Y; Maruyama I; Kobayashi S; Kobayashi K; Maezawa A; Kobayashi M; Yamazaki Y; Shibata N
Neurourol Urodyn; 2006; 25(7):792-9; discussion 800-1. PubMed ID: 16894620
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity studies on N-[5-(1H-imidazol-4-yl)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide, an imidazole-containing alpha(1A)-adrenoceptor agonist.
Altenbach RJ; Khilevich A; Kolasa T; Rohde JJ; Bhatia PA; Patel MV; Searle XB; Yang F; Bunnelle WH; Tietje K; Bayburt EK; Carroll WA; Meyer MD; Henry R; Buckner SA; Kuk J; Daza AV; Milicic IV; Cain JC; Kang CH; Ireland LM; Carr TL; Miller TR; Hancock AA; Nakane M; Esbenshade TA; Brune ME; O'Neill AB; Gauvin DM; Katwala SP; Holladay MW; Brioni JD; Sullivan JP
J Med Chem; 2004 Jun; 47(12):3220-35. PubMed ID: 15163201
[TBL] [Abstract][Full Text] [Related]
14. Effects of tamsulosin metabolites at alpha-1 adrenoceptor subtypes.
Taguchi K; Saitoh M; Sato S; Asano M; Michel MC
J Pharmacol Exp Ther; 1997 Jan; 280(1):1-5. PubMed ID: 8996174
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic characterization of CHIR 2279, an N-substituted glycine peptoid with high-affinity binding for alpha 1-adrenoceptors.
Gibbons JA; Hancock AA; Vitt CR; Knepper S; Buckner SA; Brune ME; Milicic I; Kerwin JF; Richter LS; Taylor EW; Spear KL; Zuckermann RN; Spellmeyer DC; Braeckman RA; Moos WH
J Pharmacol Exp Ther; 1996 May; 277(2):885-99. PubMed ID: 8627571
[TBL] [Abstract][Full Text] [Related]
16. The effects of tamsulosin, a high affinity antagonist at functional alpha 1A- and alpha 1D-adrenoceptor subtypes.
Noble AJ; Chess-Williams R; Couldwell C; Furukawa K; Uchyiuma T; Korstanje C; Chapple CR
Br J Pharmacol; 1997 Jan; 120(2):231-8. PubMed ID: 9117115
[TBL] [Abstract][Full Text] [Related]
17. KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model.
Akiyama K; Hora M; Tatemichi S; Masuda N; Nakamura S; Yamagishi R; Kitazawa M
J Pharmacol Exp Ther; 1999 Oct; 291(1):81-91. PubMed ID: 10490890
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of buflomedil on prostate alpha1A adrenoceptor in the Wistar rat.
Tang LM; Cheng JT; Tong YC
Neurosci Lett; 2004 Sep; 367(2):224-7. PubMed ID: 15331158
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.
Kuo GH; Prouty C; Murray WV; Pulito V; Jolliffe L; Cheung P; Varga S; Evangelisto M; Wang J
J Med Chem; 2000 Jun; 43(11):2183-95. PubMed ID: 10841797
[TBL] [Abstract][Full Text] [Related]
20. Comparison of prazosin, terazosin and tamsulosin: functional and binding studies in isolated prostatic and vascular human tissues.
Amadesi S; Varani K; Spisani L; Daniele C; Turini A; Agnello G; Zamboni P; Borea PA; Geppetti P
Prostate; 2001 Jun; 47(4):231-8. PubMed ID: 11398170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
